Aβ40 Promotes the Osteoblastic Differentiation of Aortic Valve Interstitial Cells through the RAGE Pathway

Abstract

Amyloid beta (Aβ) peptide 40 enhances the activation of receptor for advanced glycation end products (RAGE) in immune-inflammatory diseases. RAGE exhibits several effects in the setting of numerous cardiovascular events. We hypothesized that the Aβ40/RAGE pathway is involved in the osteoblastic differentiation of the valvular interstitial cell (VIC) phenotype, and RAGE knockout intervention could reduce the calcification of aortic valve interstitial cells (AVICs) by inhibiting the extracellular-regulated kinase1/2 (ERK1/2)/nuclear factor kappa-B (NF-κB) signaling pathway. To test this hypothesis, the activation of Aβ40/RAGE pathway in human calcific AVs was evaluated with immunohistochemical staining. Cultured calcific VIC models were used in vitro. The VICs were stimulated using Aβ40, with or without RAGE small interfering ribonucleic acid (siRNA), and ERK1/2 and NF-κB inhibitors for analysis. Our data revealed that Aβ40 induced the ERK1/2/NF-κB signaling pathway and osteoblastic differentiation of AVICs via the RAGE pathway in vitro.

Keywords

aortic valve calcification / amyloid β / receptor for advanced glycation end products / inflammation / osteoblastic differentiation

References

[1] CoffeyS, CairnsBJ, IungB. The modern epidemiology of heart valve disease. Heart, 2016, 102(1): 75-85

[2] LeH A, Shum-TimD. Tissue engineering of autologous heart valves: a focused update. Future Cardiol, 2014, 10(1): 93-104

[3] LeopoldJA. Cellular mechanisms of aortic valve calcification. Circ Cardiovasc Interv, 2012, 5(4): 605-614

[4] MillerJD, WeissRM, HeistadDD. Calcific aortic valve stenosis: methods, models, and mechanisms. Circ Res, 2011, 108(11): 1392-1412

[5] AlexopoulosA, KaoukisA, PapadakiH, et al.. Pathophysiologic mechanisms of calcific aortic stenosis. Ther Adv Cardiovasc Dis, 2012, 6(2): 71-80

[6] WangB, CaiZ, LiuB, et al.. RAGE deficiency alleviates aortic valve calcification in ApoE-/- mice via the inhibition of endoplasmic reticulum stress. Biochim Biophys Acta Mol Basis Dis, 2017, 1863(3): 781-792

[7] CaiZ, LiF, GongW, et al.. Endoplasmic reticulum stress participates in aortic valve calcification in hypercholesterolemic animals. Arterioscler Thromb Vasc Biol, 2013, 33(10): 2345-2354

[8] SelkoeDJ. The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer’s disease. Trends Cell Biol, 1998, 8: 447-453

[9] KokjohnTA, Van VickleGD, MaaroufCL, et al.. Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and platelets. Biochimica et Biophysica Acta, 2011, 1812: 1508-1514

[10] AudetA, CoteN, CoutureC, et al.. Amyloid substance within stenotic aortic valves promotes mineralization. Histopathology, 2012, 61: 610-619

[11] LotzM, EbertS, EsselmannH, et al.. Amyloid beta peptide 1–40 enhances the action of Toll-like receptor-2 and -4 agonists but antagonizes Toll-like receptor-9-induced inflammation in primary mouse microglial cell cultures. J Neurochem, 2005, 94: 289-298

[12] RajamannanNM. Calcific aortic stenosis: lessons learned from experimental and clinical studies. Arterioscler Thromb Vasc Biol, 2009, 29(2): 162-168

[13] SuX, AoL, ShiY, et al.. Oxidized low density lipoprotein induces bone morphogenetic protein-2 in coronary artery endothelial cells via Toll-like receptors 2 and 4. J Biol Chem, 2011, 286(14): 12213-12220

[14] LiuJ, HuangK, CaiGY, et al.. Receptor for advanced glycation end-products promotes premature senescence of proximal tubular epithelial cells via activation of endoplasmic reticulum stress-dependent p21 signaling. Cell Signal, 2014, 26(1): 110-121